Month: January 2016

Several studies presented at the 2015 ECTRIMS Conference addressed the issue of how to assess treatment response after the first year, specifically whether the appearance of new MRI lesions or new relapses is reliable. At least 7 studies have shown that newly diagnosed patients, started on interferon and assessed at 1 year, have very high… Read more »